Tesla Stock Is Down This Year, and SpaceX Is Volatile. Are Either Worth Owning Right Now?

Tesla trades around $375 with a roughly $1.2 trillion market cap despite full-year 2025 revenue falling 3% to $94.8 billion, deliveries down 8.6% to 1.64 million, and Q4 2025 net income down 61%. The article argues Tesla's 180x+ P/E leaves little room for execution risk, while SpaceX faces potential selling pressure from lockup expirations, a float that could expand up to 900%, and a Morningstar fair value estimate of $63 per share versus $154.60 trading levels. Overall, the piece is a valuation cautionary note on both names rather than a catalyst-driven update.

Analysis

The market is effectively treating both names as “belief stocks” with embedded call options on future platform dominance, but the near-term setup is asymmetrical. In TSLA, the key issue is not whether the company can eventually win in autonomy or energy; it is that a premium multiple on compressed core margins leaves no room for a slow adoption curve, and any delay in new product velocity keeps the stock hostage to narrative resets. That makes the next catalyst set-up more about disappointment risk than upside surprise: a quarter of decent margins is unlikely to re-rate the stock without evidence of accelerating units, software attach, or a material step-function in earnings power.

The more actionable dislocation is in SPCX, where the stock is facing a mechanically driven supply overhang that can persist for weeks, not days. When a float expands that quickly, price discovery tends to deteriorate because marginal buyers are forced to absorb insider supply before a durable clearing price forms; in practice, that often creates a sequence of lower highs around unlock windows rather than a single binary drop. The bond issuance adds a second-order signal: management is already pulling forward financing capacity, which can be read as confidence operationally but also as dilution/leverage risk for equity holders if capex or AI losses remain elevated.

The consensus appears to be underweighting how much of these valuations depend on scarcity and story, not just operating results. For TSLA, the bear case is less about bankruptcy and more about opportunity cost: capital tied up in a crowded, expensive equity with limited near-term catalyst density may underperform cheaper AI/industrial beta that can actually compound on visible earnings revisions. For SPCX, the contrarian view is that long-only believers may keep supply high-velocity but not necessarily one-directional; however, until the unlock calendar clears, any bounce is likely to be sold into by insiders, employees, and pre-IPO holders monetizing gains.

Key Decisions for Investors

• Short TSLA on strength into earnings or product-event rallies; use a 4-8 week horizon and target downside to the prior breakout zone, with risk defined by a sustained re-acceleration in deliveries or software monetization.
• Buy SPCX puts or put spreads into the next unlock windows; the best risk/reward is 2-6 weeks out, when supply expansion should overwhelm incremental demand and crush skew if the stock fails to absorb insider selling.
• Pair trade: short TSLA / long NVDA or AAPL for a 1-3 month relative-value position; this isolates the market’s willingness to pay for real cash-flow compounding versus narrative optionality.
• Avoid initiating new long exposure in SPCX until after the early-September unlock cluster; if the stock can hold post-supply shock, only then consider a tactical long for a mean-reversion bounce.
• If already long TSLA, reduce size rather than add hedges indiscriminately; the cleanest risk control is trimming into strength because the primary risk is valuation decay, not a single-event collapse.